News - Brightlands Venture Partners

Naar hoofdinhoud Naar hoofdnavigatiemenu

Search

Koch Technology Solutions And Ioniqa Technologies Partner To Disrupt Plastics Industry Through Advanced PET Upcycling Technology

September 13, 2022

Matisse Pharmaceuticals about to start third dose level in a Phase I/IIa study with its lead compound M6229 in septic patients

September 09, 2022

Second orphan medicinal product designation for Neuro-Cells® paves way for application to both chronic and trauma-induced neurodegenerative diseases

September 08, 2022

Brightlands Venture Partners invests in AgTech company S+dB

September 07, 2022

Verdify increases seed round to €2.1 million for accelerated rollout of personalised recipe platform

July 01, 2022

Hy2Care receives € 6M EU funding for optimal cartilage repair

June 14, 2022

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury

March 29, 2022

Mane Biotech raises € 1.7 million to further develop its regenerative medicine technology to combat hair loss

January 18, 2022

PectCof raises € 2 million for its innovative coffee pulp-based food ingredients

January 12, 2022

Verdify raises €1.3 million to scale its Swapmeals® platform for personalised recipes

December 13, 2021

Matisse Pharmaceuticals receives approval from the Dutch Health Authorities to initiate a Phase I study with lead compound M6229

November 22, 2021

Dutch stem cell biotech Neuroplast secures € 10 million in Series B funding

November 17, 2021

More information

If you have any questions or want to know more about us
Contact us